This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Ellis-van Creveld Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Ellis-van Creveld Syndrome shares some biological mechanisms with achondroplasia, bone-diseases-developmental, chondrodysplasia-punctata, congenital-abnormality, congenital-heart-defects, congenital-heart-disease, developmental-absence-of-tooth, dwarfism, dysostoses, dysplasia, dystrophy, ectodermal-dysplasia, endocardial-cushion-defects, heart-diseases, jeune-thoracic-dystrophy, osteochondrodysplasias, polydactyly, skeletal-dysplasia, tooth-abnormalities.
Among the many pathways, these few ones have gauged particular interests from scientists studying Ellis-van Creveld Syndrome, and have been seen in publications frequently: Chondrocyte Hypertrophy, Chondrocyte Proliferation, Endocardial Cushion Development, Endochondral Ossification, Heart Development, Intraflagellar Transport, Localization, Lung Growth, Mating, Ossification, Osteoblast Differentiation, Pathogenesis, Tissue Development, Tissue Homeostasis, Transport, Transposition, Tube Fusion, Wound Healing
Quite a number of genes have been found to play important roles in Ellis-van Creveld Syndrome, such as ATM, CRMP1, DCN, EVC, EVC2, FUT1, GLI1, HFE, IFT80, IHH, MSX1, MTSS1, NKX2-5, NT5E, NTS, SMO, SMOX, UCN2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.